earnings-desk

preliminary & post-call earnings reports
← all reports
SPX Post-call migrated from v1 archive

SPX — Spirax Group

H1 2026 · published 2026-08-11

SPX H1 2026 - Post-Call Earnings Update

Event: Quartr H1 2026 event Retrieved: 2026-08-11T11:42:00Z Comparison mode: maximal Scorecard contract: v1

Consensus scorecard

Metric / basis Quartr actual API Ninjas consensus Beat/Miss Beat/Miss %
Revenue / group revenue £863.8m API Ninjas estimate unavailable Not scored Not scored
EPS / adjusted basic 150.0p API Ninjas estimate unavailable Not scored Not scored

Management and Q&A

Guidance and KPI clarification

Guidance item Position on the call Position in the release Change
Group organic revenue growth, FY2026 mid-single-digit, well ahead of IP mid-single-digit, well ahead of IP reiterated
Group adjusted operating margin, FY2026 expected to increase organically on 2025 same reiterated
Full-year cash conversion around 90% "similar to 2025 levels" quantified on the call
Full-year capital expenditure lower end of a 4%-5% of sales range not carried in the pages read new on the call
FX impact, H2 2026 negligible on revenue, 2% headwind on profit negligible full-year impact at end-July rates split into halves on the call
Group H1:H2 sales split assumed 48% : 52% not disclosed new on the call
Group H1:H2 adjusted operating profit split assumed 45% : 55% disclosed for STS only extended to group on the call
STS second half higher sales growth than H1; margin higher than H1; FY margin broadly in line with 2025 same reiterated
ETS second half high-single-digit sales growth; margin slightly ahead of H1 same reiterated
WMFTS second half high-single-digit sales growth; margin broadly similar to H1 same reiterated
Delivery of FY guidance if IP stays at H1 levels still deliverable; no material IP recovery assumed not addressed new on the call
Net debt to EBITDA back inside the 1x-1.5x target range by year end 1.6x reported, no range restated new on the call
Dividend growth policy cover back in the board's target range; future growth to more closely reflect underlying earnings growth interim dividend +3% new on the call
Medium-term target restated Level Supporting detail given on the call
Group adjusted operating margin 22%-23% remainder of the journey "largely driven by ETS and Watson-Marlow"
STS margin 23.5% higher volumes, operational improvements, organisational initiatives
ETS margin 20% legacy low-margin backlog cleared; 20% already achieved in one month; pricing is upside, mainly post-2027
WMFTS margin over 30% operating leverage on a sustained higher sales level; no large facility investment needed
STS organic growth low to mid-single digit, improving within the range China back to growth adds ~3%-4%; digital and decarbonisation add ~1% to 4%-5%, before IP
ETS organic growth above mid-single digit currently delivering above that level
WMFTS organic growth high single digit Biopharm market growth plus Process Industries share gain
Disclosure made on the call Figure Prior reference
STS shipment-phasing headwind to H1 growth low single-digit millions of pounds described but unquantified in the release
Value of 1% of STS first-half sales about £4m not disclosed
Order book conversion profile ~40% booked and shipped within the month; 80%-85% within three months not disclosed
ETS single-month margin high 20%, in the highest-shipment month not disclosed
Heat Trace and semicon margins slightly over 20% not disclosed
Process heating share of ETS about 60% not disclosed
ETS sequential sales growth 10%, 12%, 11% not disclosed
Equipment heating share of ETS sales / semicon within it ~25% of ETS sales, half of it semicon (~12.5%), on 2025 numbers not disclosed
Middle East share of group sales about 1%, weighted more heavily to steam not disclosed
STS sales and technical hires around 100 colleagues added headcount +3% in the release
Time for a sales engineer to reach full run rate two to three years not disclosed
Connected steam traps 19,000 across 2,350 customer sites since 2023; ambition 100,000 not disclosed
Steam traps physically surveyed annually around one million not disclosed
Trap connection density needed for a system view around one in ten in a loop not disclosed
Thermal energy assessments delivered in H1 16, across the USA, Europe and China not disclosed
Pull-through from those assessments average over 5x initial assessment revenue not disclosed
US distributor cogeneration partners 22 onboarded in 2025, demand up about 6% not disclosed
North American ETS factory output -10% over five years to 2024; +40% since not disclosed
Restructuring cash outlay in H1 £5m, no P&L charge not disclosed in the pages read
Watson-Marlow Process Industries vs Biopharm growth rates explicitly not quantified not disclosed
Ogden under-absorption cost explicitly not quantified; no end date given not disclosed

Updated neutral analysis

Market context and limitations